MDA and trial designs to evaluate the impact of azithromycin on child mortality
- PMID: 35063109
- DOI: 10.1016/S2214-109X(21)00557-X
MDA and trial designs to evaluate the impact of azithromycin on child mortality
Conflict of interest statement
We declare no competing interests.
Comment on
-
Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial.Lancet Glob Health. 2021 Nov;9(11):e1569-e1578. doi: 10.1016/S2214-109X(21)00347-8. Epub 2021 Sep 21. Lancet Glob Health. 2021. PMID: 34559992 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
